Last updated on November 2018

A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of molidustat in non-dialysis subjects previously treated with Erythropoiesis-Stimulating Agents (ESAs)

Clinical Study Identifier: NCT03350347

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Asama Nanroku Komoro Medical Center
Komoro, Japan